Esther Hulleman

Esther Hulleman

UNVERIFIED PROFILE

Are you Esther Hulleman?   Register this Author

Register author
Esther Hulleman

Esther Hulleman

Publications by authors named "Esther Hulleman"

Are you Esther Hulleman?   Register this Author

48Publications

1500Reads

9Profile Views

Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.

EBioMedicine 2019 Nov 14. Epub 2019 Nov 14.

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Departments of Pediatric Oncology/Hematology, Emma Children's hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.10.062DOI Listing
November 2019

Preclinical therapeutic targets in diffuse midline glioma.

Drug Resist Updat 2019 05 7;44:15-25. Epub 2019 Jun 7.

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drup.2019.06.001DOI Listing
May 2019

MELK Inhibition in Diffuse Intrinsic Pontine Glioma.

Clin Cancer Res 2018 11 30;24(22):5645-5657. Epub 2018 Jul 30.

Departments of Pediatric Oncology/Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0924DOI Listing
November 2018

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.

J Clin Oncol 2018 07 10;36(19):1963-1972. Epub 2018 May 10.

Lindsey M. Hoffman and Nicholas K. Foreman, University of Colorado Denver; Lindsey M. Hoffman and Nicholas K. Foreman, Children's Hospital Colorado, Aurora, CO; Sophie E.M. Veldhuijzen van Zanten, Esther Hulleman, Gertjan J.L. Kaspers, Esther Sanchez, and Dannis G. van Vuurden, Vrije Universiteit University Medical Center, Amsterdam; William P. Vandertop, Academy of Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Niclas Colditz, Marion Hoffmann, Brigitte Bison, Monika Warmuth-Metz, and Christof M. Kramm, University Medical Center Goettingen, Goettingen; Torsten Pietsch and Gerrit H. Gielen, University of Bonn Medical Center, Bonn; David T.W. Jones, Dominik Sturm, Stefan M. Pfister, and Elke Pfaff, German Cancer Research Center, Hopp-Children's Cancer Center at the Nationale Centrum für Tumorerkrankungen Heidelberg, and German Consortium for Translational Cancer Research; Dominik Sturm, Stefan M. Pfister, and Elke Pfaff, Heidelberg University Hospital, Heidelberg, Germany; Joshua Baugh, Brooklyn Chaney, Adam Lane, Christine Fuller, Nancy Yanez Escorza, Renee Doughman, Rachid Drissi, James Leach, Blaise Jones, and Maryam Fouladi, Cincinnati Children's Hospital Medical Center, Cincinnati; Emmett Broxson, Wright State University and The Children's Medical Center, Dayton, OH; Lili Miles, Nemours Children's Hospital, Orlando, FL; Cynthia Hawkins, Ute Bartels, and Eric Bouffet, The Hospital for Sick Children, Toronto, Ontario; Anne Sophie Carret, Centre Hospitalier Universitaire Sainte-Justine; Nada Jabado, McGill University, Montreal, Quebec, Canada; Stewart Goldman, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL; Sarah Leary, Seattle Children's Hospital, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Roger Packer, Children's National Health System; Javad Nazarian, Children's National Medical Center, Washington, DC; Katherine E. Warren, National Cancer Institute, Bethesda, MD; Alberto Broniscer, St Jude Children's Research Hospital, Memphis, TN; Mark W. Kieran, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA; Jane Minturn, Children's Hospital of Philadelphia and The Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Melanie Comito, The Pennsylvania State University, Hershey, PA; Chie-Schin Shih, Indiana University, Indianapolis, IN; Soumen Khatua, The University of Texas MD Anderson Cancer Center; Murali Chintagumpala, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX; Timothy Hassall, Lady Cilento Children's Hospital, Brisbane, Queensland; David S. Ziegler, Kids Cancer Centre, Sydney Children's Hospital, Randwick; David S. Ziegler, University of New South Wales, Sydney, New South Wales; Nicholas Gottardo and Hetal Dholaria, Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Martin Benesch, Medical University of Graz, Graz, Austria; Nathalie Boddaert. Stephanie Puget, and Raphaël Calmon, Hôpital Necker Enfants Malades; Pascale Varlet, Hôpital Sainte-Anne, Université Paris V Descartes, Sorbonne Paris Cité, Paris; Géraldine Giraud, David Castel, and Jacques Grill, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France; Géraldine Giraud, Uppsala University, Uppsala, Sweden; Chris Jones, The Institute of Cancer Research, Sutton; Darren Hargrave, Great Ormond Street Hospital, London; Guirish A. Solanki, Birmingham Women's and Children's Hospital, Birmingham; Simon Bailey, Great North Children's Hospital, Victoria Wing, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom; Piergiorgio Modena and Marzia Giagnacovo, Sant' Anna Como General Hospital, Como; Manila Antonelli, Sapienza University of Rome, Rome; Veronica Biassoni and Maura Massimino, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy; Nicolas U. Gerber and Michael A. Grotzer, University Children's Hospital of Zurich, Zurich; André O. von Bueren, University Hospital of Geneva and University of Geneva, Geneva, Switzerland; and Filip Jadrijevic Cvrlje and Gertjan J.L. Kaspers, Children's Hospital Zagreb, Zagreb, Croatia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.9308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075859PMC
July 2018

Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Cell Mol Life Sci 2018 03 21;75(5):871-887. Epub 2017 Nov 21.

Departments of Pediatric Oncology/Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-017-2714-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809527PMC
March 2018

An efficient method for the transduction of primary pediatric glioma neurospheres.

MethodsX 2018 27;5:173-183. Epub 2018 Feb 27.

Departments of Pediatric Oncology/Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mex.2018.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318100PMC
February 2018

Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies.

Exp Cell Res 2017 11 22;360(2):397-403. Epub 2017 Sep 22.

Departments of Pediatric Oncology / Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2017.09.032DOI Listing
November 2017

Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma.

Oncotarget 2017 Oct 8;8(45):78978-78988. Epub 2017 Sep 8.

Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20741DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668013PMC
October 2017

Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma.

Oncotarget 2017 09 31;8(36):60447-60452. Epub 2017 Jul 31.

VU University Medical Center, Department of Paediatrics, Division of Oncology/Haematology, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601151PMC
September 2017

Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.

Cancer Cell 2017 05 20;31(5):635-652.e6. Epub 2017 Apr 20.

Department of Neurology, Stanford University, Palo Alto, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, California 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2017.03.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462626PMC
May 2017

Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease.

J Neurooncol 2017 04 21;132(2):255-266. Epub 2017 Jan 21.

Department of Paediatrics, Division of Oncology/Haematology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2363-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378734PMC
April 2017

Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models.

Mol Cancer Ther 2016 09 20;15(9):2166-74. Epub 2016 Jun 20.

Department of Pediatrics, Pediatric Hematology and Oncology, Cancer Center, Amsterdam, the Netherlands. Neuro-oncology Research Group Cancer Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0558DOI Listing
September 2016

Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.

J Neurosci Methods 2014 Dec 27;238:88-94. Epub 2014 Sep 27.

Department of Pediatric Oncology, VU University Medical Center, Amsterdam, The Netherlands; Neuro-oncology Research Group, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneumeth.2014.09.020DOI Listing
December 2014

Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.

Sci Rep 2014 Jun 11;4:5260. Epub 2014 Jun 11.

1] Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands [2] Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands [3] Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep05260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052714PMC
June 2014

EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.

Neuro Oncol 2012 Sep 21;14(9):1125-35. Epub 2012 Jun 21.

Department of Pediatric Oncology/Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nos130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424207PMC
September 2012

EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.

Clin Cancer Res 2012 Aug 13;18(15):4048-58. Epub 2012 Jun 13.

Neuro-oncology Research Group, Department of Neurosurgery, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0399DOI Listing
August 2012

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.

Oncotarget 2011 Dec;2(12):984-96

Department of Pediatric Oncology / Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282104PMC
http://dx.doi.org/10.18632/oncotarget.362DOI Listing
December 2011

Blood platelets contain tumor-derived RNA biomarkers.

Blood 2011 Sep 10;118(13):3680-3. Epub 2011 Aug 10.

Neuro-oncology Research Group, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-03-344408DOI Listing
September 2011

Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study.

Tumori 2010 Jan-Feb;96(1):97-102

Department of Neurosurgery, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
May 2010

Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.

Blood 2009 Feb 31;113(9):2014-21. Epub 2008 Oct 31.

Department of Pediatric Oncology and Hematology, Erasmus Medical Center-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-05-157842DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081395PMC
February 2009

Molecular mechanisms in gliomagenesis.

Adv Cancer Res 2005 ;94:1-27

European Institute of Oncology, Department of Experimental Oncology, 20141 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0065-230X(05)94001-3DOI Listing
September 2005